Sign up to save your podcasts
Or
Share Morgan Stanley (MS)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Morgan Stanley (MS)
$MS has released its Q4 2024 earnings, showing a solid EPS of $2.22, beating expectations by $0.54, and revenues of $16.22B, up 25.8% Y/Y, exceeding estimates. Strong financial health is highlighted by a 71.1% efficiency ratio and a 20.2% return on tangible capital.
The firm's growth strategy remains robust, with optimism for M&A activity in 2025. However, geopolitical tensions and market fluctuations pose potential risks.
For more insights, check the full report at http://valueverge.com/MS.
View all episodes
By ValueVerge$MS has released its Q4 2024 earnings, showing a solid EPS of $2.22, beating expectations by $0.54, and revenues of $16.22B, up 25.8% Y/Y, exceeding estimates. Strong financial health is highlighted by a 71.1% efficiency ratio and a 20.2% return on tangible capital.
The firm's growth strategy remains robust, with optimism for M&A activity in 2025. However, geopolitical tensions and market fluctuations pose potential risks.
For more insights, check the full report at http://valueverge.com/MS.